We were happy to represent our clients, Vertex Ventures and Grove Ventures, as part of their investment in the $22 Million Series B investment round, led by Alive, in Navina.
Navina uses medically-informed AI to provide primary care physicians with the right information at the right time.
The Investors were represented by partner Roy Caner and senior associate Oded Natan from our Hi-Tech, Corporate and M&A Department.
To read the full (Hebrew) article, click here.
+97237770120 
